Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women

被引：0
|
作者：
Vanessa Dumeaux
Agnès Fournier
Eiliv Lund
Françoise Clavel-Chapelon
机构：
[1] University of Tromsø,Institute of Community Medicine
[2] INSERM “Nutrition,Institut Gustave
[3] Hormones,Roussy
[4] Cancer”,undefined
[5] Equipe E3N-EPIC,undefined
来源：
Cancer Causes & Control | 2005年 / 16卷
关键词：
breast cancer; postmenopausal women; oral contraceptives; patterns of use; hormone replacement therapy.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：537 / 544
页数：7
相关论文
共 50 条
  • [1] Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women
    Dumeaux, V
    Fournier, A
    Lund, E
    Clavel-Chapelon, F
    [J]. CANCER CAUSES & CONTROL, 2005, 16 (05) : 537 - 544
  • [2] Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women
    Norman, SA
    Berlin, JA
    Weber, AL
    Strom, BL
    Daling, JR
    Weiss, LK
    Marchbanks, PA
    Bernstein, L
    Voigt, LF
    McDonald, JA
    Ursin, G
    Liff, JM
    Burkman, RT
    Malone, KE
    Simon, MS
    Folger, SG
    Deapen, D
    Wingo, PA
    Spirtas, R
    [J]. CANCER CAUSES & CONTROL, 2003, 14 (10) : 933 - 943
  • [3] Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women
    Sandra A. Norman
    Jesse A. Berlin
    Anita L. Weber
    Brian L. Strom
    Janet R. Daling
    Linda K. Weiss
    Polly A. Marchbanks
    Leslie Bernstein
    Lynda F. Voigt
    Jill A. McDonald
    Giske Ursin
    Jonathan M. Liff
    Ronald T. Burkman
    Kathleen E. Malone
    Michael S. Simon
    Suzanne G. Folger
    Dennis Deapen
    Phyllis A. Wingo
    Robert Spirtas
    [J]. Cancer Causes & Control, 2003, 14 : 933 - 943
  • [4] Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women
    Kabat, Geoffrey C.
    Miller, Anthony B.
    Rohan, Thomas E.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (03) : 643 - 646
  • [5] Hormone replacement therapy and previous use of oral contraceptives among Swedish women
    Hammar, M
    Brynhildsen, J
    Dabrosin, L
    Frisk, J
    Lindgren, R
    Nedstrand, E
    Wyon, Y
    [J]. MATURITAS, 1996, 25 (03) : 193 - 199
  • [6] The effect of hormone replacement therapy, previous oral contraceptive use and lifetime estrogen and progestin exposure on intraocular pressure in postmenopausal women
    Abramov, Y
    Borik, S
    Yahalom, C
    Fatum, M
    Avgil, G
    Brzezinsky, A
    Banin, E
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 577 - 577
  • [7] Previous oral contraceptive use and breast cancer risk among pre- and postmenopausal women - retrospective study in a cohort of 979 patients
    Lumachi, F.
    Basso, S. M. M.
    Marzano, B.
    Bonamini, M.
    Waclaw, B. U.
    Chiara, G. B.
    [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 220 - 220
  • [8] Hormone replacement therapy and the risk of breast cancer among postmenopausal women.
    Kirsh, V
    Kreiger, N
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S34 - S34
  • [9] Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy
    Armstrong, K
    Popik, S
    Guerra, C
    Ubel, PA
    [J]. MEDICAL DECISION MAKING, 2000, 20 (03) : 308 - 313
  • [10] Risk of second breast cancer according to hormone therapy use among women with carcinoma in situ of the breast
    Trentham-Dietz, A.
    Newcomb, P. A.
    Nichols, H. B.
    Hampton, J. M.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (02) : 460 - 460
12345